Immunic
IMUX
IMUX
54 hedge funds and large institutions have $27M invested in Immunic in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less call options, than puts
Call options by funds: $145K | Put options by funds: $267K
47% less capital invested
Capital invested by funds: $50.7M → $27M (-$23.7M)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Holders
54
Holding in Top 10
1
Calls
$145K
Puts
$267K
Top Buyers
| 1 | +$621K | |
| 2 | +$281K | |
| 3 | +$269K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$235K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
+$127K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$1.23M | |
| 3 | -$774K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$547K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$294K |